cancer. Malignant neoplasm of central portion of breast
Conditions
Interventions
Intervention 1: Intervention group: At first, 30 people were randomly selected from permutation block and received a 450 mg curcumin tablet daily and at intervals before the intervention, 3 and 6 wee
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 30 to 60 years Definitive diagnosis of cancer that chemotherapyeutic treatment is indicated . Treated with a regimen containing paclitaxel and docetaxel Ability to take oral medication
Exclusion criteria
Exclusion criteria: Gastrointestinal bleeding pregnancy and Breastfeeding using heparin, aspirin, Clopidogrel, dipiridamol ,warfarin and ticlopidine Past medical history of hepatic disease Past medical history of peptic ulcer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Aspartate Aminotransferase. Timepoint: before intervention and 3 and 6 weeks after intervention. Method of measurement: laboratory.;Alanine transaminase. Timepoint: before intervention and 3 and 6 weeks after intervention. Method of measurement: laboratory.;Alkaline phosphatase. Timepoint: before intervention and 3 and 6 weeks after intervention. Method of measurement: laboratory.;Bilirubin. Timepoint: before intervention and 3 and 6 weeks after intervention. Method of measurement: laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Hajgholami
Esfahan University of Medical Sciences
Outcome results
None listed